Literature DB >> 12740060

Regulation of short-chain fatty acid production.

Sandra Macfarlane1, George T Macfarlane.   

Abstract

Short-chain fatty acid (SCFA) formation by intestinal bacteria is regulated by many different host, environmental, dietary and microbiological factors. In broad terms, however, substrate availability, bacterial species composition of the microbiota and intestinal transit time largely determine the amounts and types of SCFA that are produced in healthy individuals. The majority of SCFA in the gut are derived from bacterial breakdown of complex carbohydrates, especially in the proximal bowel, but digestion of proteins and peptides makes an increasing contribution to SCFA production as food residues pass through the bowel. Bacterial hydrogen metabolism also affects the way in which SCFA are made. This outcome can be seen through the effects of inorganic electron acceptors (nitrate, sulfate) on fermentation processes, where they facilitate the formation of more oxidised SCFA such as acetate, at the expense of more reduced fatty acids, such as butyrate. Chemostat studies using pure cultures of saccharolytic gut micro-organisms demonstrate that C availability and growth rate strongly affect the outcome of fermentation. For example, acetate and formate are the major bifidobacterial fermentation products formed during growth under C limitation, whereas acetate and lactate are produced when carbohydrate is in excess. Lactate is also used as an electron sink in Clostridium perfringens and, to a lesser extent, in Bacteroides fragilis. In the latter organism acetate and succinate are the major fermentation products when substrate is abundant, whereas succinate is decarboxylated to produce propionate when C and energy sources are limiting.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740060     DOI: 10.1079/PNS2002207

Source DB:  PubMed          Journal:  Proc Nutr Soc        ISSN: 0029-6651            Impact factor:   6.297


  413 in total

1.  Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations.

Authors:  Junhai Ou; James P DeLany; Ming Zhang; Sumit Sharma; Stephen J D O'Keefe
Journal:  Nutr Cancer       Date:  2011-12-02       Impact factor: 2.900

2.  Shifting from a gene-centric to metabolite-centric strategy to determine the core gut microbiome.

Authors:  Julian R Marchesi
Journal:  Bioeng Bugs       Date:  2011-11-01

3.  Phylogenetic analysis of 16S rRNA gene sequences reveals distal gut bacterial diversity in wild wolves (Canis lupus).

Authors:  Honghai Zhang; Lei Chen
Journal:  Mol Biol Rep       Date:  2010-03-20       Impact factor: 2.316

Review 4.  Essential roles of four-carbon backbone chemicals in the control of metabolism.

Authors:  Sabrina Chriett; Luciano Pirola
Journal:  World J Biol Chem       Date:  2015-08-26

5.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

6.  A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids.

Authors:  Xiaojiao Zheng; Yunping Qiu; Wei Zhong; Sarah Baxter; Mingming Su; Qiong Li; Guoxiang Xie; Brandon M Ore; Shanlei Qiao; Melanie D Spencer; Steven H Zeisel; Zhanxiang Zhou; Aihua Zhao; Wei Jia
Journal:  Metabolomics       Date:  2013-08-01       Impact factor: 4.290

7.  VEGF-C mediated enhancement of lymphatic drainage reduces intestinal inflammation by regulating IL-9/IL-17 balance and improving gut microbiota in experimental chronic colitis.

Authors:  Xiaolei Wang; Jin Zhao; Li Qin
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.

Authors:  Ernst Fredericks; Reza Theunissen; Saartjie Roux
Journal:  Turk J Gastroenterol       Date:  2020-12       Impact factor: 1.852

9.  Gut microbiota-produced succinate promotes C. difficile infection after antibiotic treatment or motility disturbance.

Authors:  Jessica A Ferreyra; Katherine J Wu; Andrew J Hryckowian; Donna M Bouley; Bart C Weimer; Justin L Sonnenburg
Journal:  Cell Host Microbe       Date:  2014-12-10       Impact factor: 21.023

Review 10.  The gut microbiome and HIV-1 pathogenesis: a two-way street.

Authors:  Stephanie M Dillon; Daniel N Frank; Cara C Wilson
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.